Article Sidebar

PDF
Date Published: 31/07/2022
Abstract Views: 485
Views PDF: 242
DOI: https://doi.org/10.51298/vmj.v516i2.3092
Issue
Vol. 516 No. 2 (2022)
Section
Các bài báo
How to Cite
Ngọc Lan Hương, L. ., Thanh Sang, H. ., Ngọc Khôi, N. ., & Như Hồ, N. . (2022). EVALUATION OF DRUG DOSAGE ADJUSTMENT IN PATIENTS WITH RENAL IMPAIRMENT AT GIA DINH PEOPLE’S HOSPITAL. Vietnam Medical Journal, 516(2). https://doi.org/10.51298/vmj.v516i2.3092

EVALUATION OF DRUG DOSAGE ADJUSTMENT IN PATIENTS WITH RENAL IMPAIRMENT AT GIA DINH PEOPLE’S HOSPITAL

Lương Ngọc Lan Hương1, Huỳnh Thanh Sang2, Nguyễn Ngọc Khôi1, Nguyễn Như Hồ1,
1 University of Medicine and Pharmacy at Ho Chi Minh City
2 Ho Chi Minh City University of Technology

Main Article Content

Abstract

Objective: To evaluate the appropriateness in dosage adjustments among inpatients with renal impairment. Materials and methods: A retrospective descriptive study was conducted on patients with CrCl of < 60 mL/min admitted to at Gia Dinh People’s Hospital from January 1st to January 31st 2021. The data collected for analysis included characteristics of patients with renal impairment, appropriateness of dosage adjustments and associated factors. Drug dosage adjustment was considered appropriate if followed information from product summary characteristics. Results: A total of 4150 drug orders were prescribed for 111 patients, of which, 603 (14.5%) required dose adjustments. Approximately 37.1% (225/603) were adjusted inappropriately. Antibiotics were the most common drug class that needed adjustments (65.5%). The rates of inappropriate dose adjustments for levofloxacin, piperacillin/tazobactam and ciprofloxacin were 63.4%; 22.4% and 45.8%, respectively. Geriatrics department, renal comorbidities, and the number of drugs requiring renal dose adjustment were factors that associated with inappropriate dose adjustments. Conclusions: It is necessary to monitor and counsel healthcare professionals about renal dosage adjustments.

Article Details

Keywords

renal impairment, dose adjustment

References

1. Munar M. Y. , Singh H. (2007), "Drug dosing adjustments in patients with chronic kidney disease", Am Fam Physician, 75 (10), 1487-1496.
2. Lea-Henry T. N., Carland J. E., Stocker S. L. et al. (2018), "Clinical Pharmacokinetics in Kidney Disease: Fundamental Principles", Clin J Am Soc Nephrol, 13 (7), 1085-1095.
3. Gabardi S. , Abramson S. (2005), "Drug dosing in chronic kidney disease", Med Clin North Am, 89 (3), 649-687.
4. Hanlon J. T., Wang X., Handler S. M. et al. (2011), "Potentially inappropriate prescribing of primarily renally cleared medications for older veterans affairs nursing home patients", J Am Med Dir Assoc, 12 (5), 377-383.
5. Gansevoort R. T., Correa-Rotter R., Hemmelgarn B. R. et al. (2013), "Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention", Lancet, 382 (9889), 339-352.
6. Bennett A. C., Bennett C. L., Witherspoon B. J. et al. (2019), "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency", Expert Opin Drug Saf, 18 (11), 1055-1063.
7. Tanner C., Wang G., Liu N. et al. (2019), "Metformin: time to review its role and safety in chronic kidney disease", Med J Aust, 211 (1), 37-42.
8. Modig S., Lannering C., Östgren C. J. et al. (2011), "The assessment of renal function in relation to the use of drugs in elderly in nursing homes; a cohort study", BMC geriatrics, 11 (1), 1-6.